Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats

• Published in: Marine drugs 2023-11, Vol.21 (11), p.592
• Main Authors: Koshak, Maimonah Fuad, El-Readi, Mahmoud Zaki, Elzubier, Mohamed Elzubier, Refaat, Bassem, Almaimani, Riyad Adnan, Idris, Shakir, Althubiti, Mohammad, Al-Amodi, Hiba Saeed, Eid, Safaa Yehia
• Format: Article
• Language: English
• Subjects: Acetaminophen; Algae; Analgesics; Anti-inflammatory drugs; Antioxidants; Biological stress; Biomarkers; Blood; Carotenoids; Complications and side effects; Cytochrome; Diabetes mellitus; Drug dosages; Drug therapy; Drugs; Enzymes; Fucoxanthin; Gene expression; Genes; Health aspects; Hepatotoxicity; Immunohistochemistry; inflammation; Inflammatory diseases; Injuries; Interleukins; Liver; Liver diseases; liver injury; Metabolism; Metabolites; NF-κB protein; Nitric-oxide synthase; Nucleotide sequence; Overdose; Oxidative stress; Paracetamol; PCR; Pharmaceutical research; Proteins; Seaweeds; Serum; Serum levels; Toxicity; Tumor necrosis factor-α; Western blotting
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md21110592

Paracetamol or acetaminophen (PAC) is a commonly used analgesic and antipyretic drug. It has been shown that overdoses beyond the therapeutic range can cause hepatotoxicity and acute liver injury. The most common cause of drug-induced liver injury (DILI) in Saudi Arabia and worldwide is paracetamol overdose. Fucoxanthin (FUC) is an allenic carotenoid that is found in edible brown seaweeds, and it has antioxidant and anti-inflammatory effects. Several studies have shown the potential therapeutic effects of FUC in diabetes, cancers, and inflammatory disorders. This study aims to investigate the protective effect of FUC against PAC-induced acute liver injury in rats. FUC was administered (100, 200, and 500 mg/kg, p.o.) for 7 days, and then the liver injury was induced by the administration of PAC (2000 mg/kg, oral). Blood and liver tissue samples were collected from PAC-positive untreated, treated, and negative control rats. Biochemical and inflammatory parameters in the blood were measured. In addition, RT-PCR, Western blotting, and immunohistochemistry were performed for liver tissue. The serum levels of liver biomarkers (ALT, AST, and ALP) increased after PAC-induced liver toxicity; FUC-treated rats showed lower levels compared to the positive control. There was an increase in the expression of TNF-α, IL-1, IL-6, NF-kB, INF-γ, and iNOS and a decrease in IL-10, IL-22, and IL-10R expression after the FUC treatment of injured liver rats. For the hepatic inflammation and PAC-toxicity-induced oxidative stress genes and proteins, FUC-treated rats (100, 200, and 500 mg/kg) showed a reduction in the expression of oxidative stress genes. These results showed that FUC protected the liver against PAC-induced injury through antioxidant and anti-inflammatory actions. However, further clinical studies are required to confirm the findings.